It was observed that chronic treatment with pyrrolidine dithiocarbamate (PDTC), a NF-κB inhibitor, effectively blocked the activation of renal TLR4, NF-κB, and IL-6, without interfering with blood glucose levels in rats with STZ-induced DKD [134]. Here, IL6 is linked to diabetic kidney disease.